Gary S. Jacob, Director at Virpax Pharmaceuticals, Inc. (VRPX), bought 3,500 shares at $6.79 ($24K) on 2021-02-17, disclosed to the SEC on 2021-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HEPA | BUY | 2020-12-01 | $20K | — | Filing → |
| CRDF | BUY | 2020-05-18 | $25K | — | Filing → |
| SGYP | BUY | 2017-05-30 | $20K | — | Filing → |